Reduced bone density in patients with inflammatory bowel disease

Gut

Volumn 40, Issue 2, 1997, Pages 228-233

  Bjarnason, I ^a   Macpherson, A ^a   Mackintosh, C ^a   Buxton Thomas, M ^a   Forgacs, I ^a   Moniz, C ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Hip bone density; Inflammatory bowel disease; Vertebral bone density

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CALCIUM HOMEOSTASIS; CROHN DISEASE; ENTERITIS; FEMALE; HIP; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0031049121     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.2.228     Document Type: Article

References (30)

1. Genant HK, Mall JC, Wagonfield JB, et al. Skeletal demineralisation and growth retardation in inflammatory bowel disease. Invest Radiol 1976; 11: 541-9.
2. Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28: 410-5.
3. Genant HK, Cann CE, Ettinger B, Gordon GS. Quantitative computed tomography of vertebral spongiosa. A sensitive method for detecting early hone loss after oophorectomy. Ann Int Med 1982; 97: 699-705.
4. Fromm H. Consequences of reduced absorption: stone and bone disease. In: Scholmeric J, Kruis W, Goebell H, Hohenberger W, Gross V, eds. Inflammatory bowel disease. Pathophysiology as basis of treatment. Falk Symposium 67. Dordrecht: Kluwer Academic Publishers, 1993: 231-9.
5. Leichtmann G, Bengoa JM, Bolt MJG, Sitrin MD. Intestinal absorption of calciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. Am J Clin Nutr 1991; 54: 548-52.
6. Harries AD, Brown R, Heatley RV, Williams LA, Woodhead JS, Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 1985; 26: 1197-203.
7. Clements D, Compston JE, Evans WD, Rhodes J. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut 1993; 34: 1543-6.
8. Vogelsang H, Ferenci P, Woloszenzk W, et al. Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci 1989; 34: 1094-9.
9. Best WR, Becktel JM, Singleton JW, Kern R. Development of a Crohn's disease activity index. Gastroenterology 1976; 70: 439-44.
10. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. BMJ 1955; 2: 1041-4.
11. Suleiman S. A screening questionnaire for post-menopausal osteopenia. [PhD thesis]. London: University of London, 1991.
12. Kanis JA, Melton J, Christiansen C, Johnston CC, Khaltev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-41.
13. Melkko J, Seija N, Risteli J. Radioimmunoassay of the carboxy-terminal propeptide of human type I procollagen. Clin Chem 1990; 39: 1328-32.
14. Monaghan D, Power M, Fottrell P. Sandwich enzyme immunoassay of osteocalcin in serum with an antibody against human osteocalcin. Clin Chem 1993; 36: 942-7.
15. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal teleopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993; 39: 63-40.
16. Pigot F, Roux C, Chaussade S, et al. Low bone density in patients with inflammatory bowel disease. Dig Dis Sci 1992; 37: 1396-403.
17. Prince RL, Smith M, Dick IM, et al. Prevention of post-menopausal osteoporosis. N Engl J Med 1991; 325: 1189-95.
18. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994; 107: 1031-9.
19. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112: 352-64.
20. Slemenda CW, Hui SL, Longcope C, Johnston CC. Cigarette smoking, obesity, and bone mass. J Bone Miner Res 1989; 4: 737-41.
21. Hopper JL, Seeman E. The bone density of female twins discordant for tobacco use. N Engl J Med 1994; 330: 387-92.
22. Hassanger C, Fabbri-Mabelli G, Christiansen C. The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type 1 collagen. Osteoporosis Int 1993; 3: 50-2.
23. Johansen JS, Riis BJ, Delmas PD, Christiansen C. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 1988; 18: 191-5.
24. Fiocchi C. Production of inflammatory cytokines in the intestinal lamina propria. Immun Res 1991; 10: 239-46.
25. Mueller C, Knoflach P, Zielenski CC. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology 1990; 98: 639-46.
26. Gross V, Andus T, Caesar I, Roth M, Scholmerich J. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 1992; 102: 514-9.
27. Duane P, Teahon K, Crabtree JE, Levi AJ, Heatley RV, Bjarnason I. The relationship between nutritional status and serum interleukin 2 receptor concentrations in patients with Crohn's disease treated with elemental diet. Clin Nutr 1991; 10: 222-7.
28. Meghji S. Bone remodelling. Br Dental J 1992; 172: 235-42.
29. Thomson BM, Saklatvala J, Chambers TJ. Osteoblasts mediate interleukin-1 on bone turnover in normal mice. J Exp Med 1986; 164: 104-12.
30. Mekhjian HS, Swite DM, Melnyk CS, Rankin GB, Brooks RK. Clinical features and natural history of Crohn's disease. Gastroenterology 1979; 77: 898-906.